vision issues with tirzepatide Diabetic Retinopathy Risk: Monitoring and Safety Ozempic and vision loss: GLP-1

BPC-157 Max can be used during or after an advanced supplementation cycle to support tissue health and accelerate recovery

Peptide Protocols Precision peptide therapy Monthly subscription protocols with physician oversight, concierge support, and ongoing adjustments, built around your biology

NAD+ 1,000 mg Vial Concentration and Draw Chart Vial setup 1,000 mg + 10 mL Concentration 100 mg/mL Selected amount 25 mg Draw volume 0.25 mL U-100 units 25 units Syringe note Fits a 0.5 mL syringe Vial setup 1,000 mg + 10 mL Concentration 100 mg/mL Selected amount 50 mg Draw volume 0.50 mL U-100 units 50 units Syringe note Fits a 0.5 mL syringe Vial setup 1,000 mg + 10 mL Concentration 100 mg/mL Selected amount 75 mg Draw volume 0.75 mL U-100 units 75 units Syringe note Exceeds 0.5 mL

HK: Funding acquisition, Writing review & editing